In 2008, a previously unknown Escherichia coli clonal group, sequence type 131 (ST131),
was identified on three continents. Today, ST131 is the predominant E. coli lineage among …

Extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae present an ever-
growing burden in the hospital and community settings, across all ages and demographics …

Objectives The global increase in ESBL-producing Escherichia coli is associated with the
ST131 clonal group, especially its CTX-M-15-producing H 30Rx subset. To understand the …

Abstract Background South-Asia is known as a hub for multidrug-resistant (MDR) bacteria.
Unfortunately, proper surveillance and documentation of MDR pathogens is lacking in …

Background Enterobacteriaceae infections resistant to extended-spectrum β-lactams are an
emerging problem in children. We used a large database of clinical isolates to describe the …

Background The β-lactam antibiotics have traditionally been the main treatment of
Enterobacteriaceae infections, nonetheless, the emergence of species producing β …

Objectives Determining the prevalence of children in day-care centres (DCCs) carrying
faecal extended-spectrum β-lactamase (ESBL)-producing Enterobacteriaceae and …

Background Community acquired infections due to extended-spectrum beta-lactamase-
producing Enterobacteriaceae (ESBL-PE) had been increased. The fecal flora of children in …

Drug-resistant Klebsiella pneumoniae, especially extended-spectrum β-lactamase (ESBL)-
and/or AmpC β-lactamase-producing strains, is an emerging problem worldwide. However …

Background The escalating incidence of invasive disease caused by multidrug-resistant
Gram-negative enteric Enterobacteriaceae (MDR-GNE) is a global concern. Scant published …